GlaxoSmithKline Biologicals SA
FDA inspection history on file, 2026
- 1
- Form 483
Every document, by year
- Form 483
2026: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2026One Form 483.
Cited most
Across all GlaxoSmithKline Biologicals observations on file
- 21 CFR 211.100Written procedures; deviations2
- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.42Design and construction features1
- 21 CFR 211.68Automatic, mechanical, and electronic equipment1
The complete GlaxoSmithKline Biologicals file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2026-02-27 | 483 Form 483 | — | 6 | $99 |
FEI number 3003973577 · most recent document Feb 27, 2026
About GlaxoSmithKline Biologicals SA
How many FDA Form 483s has GlaxoSmithKline Biologicals SA received?
FDA Intel has 1 Form 483 on file for GlaxoSmithKline Biologicals SA; the most recent is dated Feb 27, 2026.
When was GlaxoSmithKline Biologicals SA last inspected by FDA?
The most recent FDA inspection document on file for GlaxoSmithKline Biologicals SA is a Form 483 dated Feb 27, 2026.
What did FDA cite at GlaxoSmithKline Biologicals SA?
The regulations cited most in the observations on file for GlaxoSmithKline Biologicals SA are 21 CFR 211.100 (Written procedures; deviations), 2 times; 21 CFR 211.113 (Control of microbiological contamination), 2 times; 21 CFR 211.42 (Design and construction features), 1 time.